Dr. Regev is the head and executive vice president of Genentech Research and Early Development (gRED), where she oversees all aspects of the company's drug discovery and early development activities. She also served as a professor of biology at MIT and a member of the executive leadership teams of the Broad Institute of MIT and Harvard.

Dr. Regev was selected for this award because of her highly impactful contributions to computational methodologies and resources for biological discovery. Her work pioneered computational methods in single cell and spatial genomics, which are widely used in biomedical research. As a founder and co-chair of the international Human Cell Atlas (HCA) project, she is helping to build a complete compendium of human cell types to advance our understanding of disease mechanisms.

Dickson Prize in Science Award Ceremony and Lecture

As part of the University Lecture Series, Dr. Regev will receive her award and present the annual Dickson Prize in Science lecture on Wednesday, March 11, 2026. Information and registration details will be shared ahead of the event.